<i>NFATC1</i> activation by <scp>DNA</scp> hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib

Christine Wolf(German Cancer Research Center), Daniel Mertens(German Cancer Research Center)
International Journal of Cancer
September 18, 2017
Cited by 38


Related Papers